Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Exacerbation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03029156
What this trial is testing

Effectiveness of the Aeroneb in Acute Severe Asthma

Who this might be right for
Asthma Exacerbation
Tufts Medical Center 31
Post-approval studies (Phase 4)Study completedNCT00273962
What this trial is testing

A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg)

Who this might be right for
Asthma
Boehringer Ingelheim 500
Not applicableEnded earlyNCT04576936
What this trial is testing

AIRVO Device Intervention for Moderate to Severe COPD

Who this might be right for
COPDCOPD Exacerbation
Renown Health 1
Post-approval studies (Phase 4)Not Yet RecruitingNCT06818019
What this trial is testing

Withdrawal of Dupilumab in Severe Asthma

Who this might be right for
Severe Asthma
University Hospital, Toulouse 205
Not applicableStudy completedNCT05407272
What this trial is testing

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care

Who this might be right for
Alzheimer Disease, Late OnsetStrokeHeart Failure+5 more
Wen-Shiou Pan 60
Large-scale testing (Phase 3)Study completedNCT02138916
What this trial is testing

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Who this might be right for
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca 1,656
Not applicableStudy completedNCT05292365
What this trial is testing

Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe CP

Who this might be right for
Cerebral Palsy
University of Wisconsin, Madison 60
Not applicableActive Not RecruitingNCT00555607
What this trial is testing

Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease

Who this might be right for
AsthmaCOPD
Karolinska Institutet 233
Not applicableUnknownNCT04842344
What this trial is testing

ECCO2R in the Treatment of Acute Exacerbation of COPD With Severe Hypercapnia

Who this might be right for
Lung Diseases, Obstructive
Li Xuyan 176
Large-scale testing (Phase 3)Study completedNCT04718389
What this trial is testing

GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Who this might be right for
Asthma
GlaxoSmithKline 1,717
Not applicableNot Yet RecruitingNCT07081776
What this trial is testing

Evaluation of the Effects on Carbon Dioxide (paCO2) of a New Oronasal Mask in Patients With Severe COPD Exacerbation Requiring Non-Invasive Mechanical Ventilation

Who this might be right for
COPDRespiratory Acidosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 21
Large-scale testing (Phase 3)Study completedNCT02555371
What this trial is testing

Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients

Who this might be right for
Asthma
GlaxoSmithKline 306
Testing effectiveness (Phase 2)Ended earlyNCT03345407
What this trial is testing

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 943
Post-approval studies (Phase 4)Not Yet RecruitingNCT07587658
What this trial is testing

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Regeneron Pharmaceuticals 754
Post-approval studies (Phase 4)Looking for participantsNCT06705764
What this trial is testing

Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

Who this might be right for
Severe Asthma
University of Alberta 100
Post-approval studies (Phase 4)Study completedNCT00393367
What this trial is testing

Budesonide Inhalation Suspension for Acute Asthma in Children

Who this might be right for
AsthmaAcute AsthmaReactive Airway Exacerbation
Children's Hospital of Philadelphia 179
Post-approval studies (Phase 4)Looking for participantsNCT07192016
What this trial is testing

129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Western University, Canada 60
Large-scale testing (Phase 3)Study completedNCT01120691
What this trial is testing

Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 2,224
Not applicableStudy completedNCT04959955
What this trial is testing

Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection

Who this might be right for
CAPCOPD Exacerbation
Peking University Third Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05692180
What this trial is testing

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma

Who this might be right for
Asthma
AstraZeneca 94
Next Page